Document mqwx0j3E6yy0D9OYbaQqNYrbb

From: Sent: To: Subject: Matt Todd <ToddM@api.org> Friday, July 9, 2004 5:53 PM (GMT) BHRC Oversight Committee (E-mail) <benzconsort-oc@listserve.api.org>; BHRC Technical Committee (E-mail) <benzconsort-tc@listserve.api.org>; BHRC Communications Committee (E-mail) <benzconsort-cc@listserve.api.org> Shanghai Health Study Update: July 9, 2004 Shanghai Health Study Update Announcements: The 1Q04 financial report has been finalized and posted on the Financials page of the SHS website. Information packets will be mailed next week to all individuals registered to attend the SHS Annual Meeting at Asilomar. If you have any announcements that you would like to be posted, please send an email to Matt Todd at toddm@api.org. BHRC-TC I Investigator Call Summary: June 2004 study update from Drs. Wong & Irons: Research & travel expenditures within approved budget at this point in study Clinical lab operations remain at full capacity 2Q04 pathology review demonstrated 99+% diagnostic concordance Leukemia cases above, lymphoma cases below predicted accrual rate Pathology department referral of NHL cases will be revisited Numbers of confirmed cases will be updated in mid-year progress report "Control Selection" issues resolved by exclusion of out-patient Controls Exposure reconstruction, exposure assessment progress will be featured in Asilomar presentations Outreach anticipated as an informal discussion topic at annual conference Munich Benzene Symposium likely to provide first venue for study-related presentations Next PI calls scheduled for July 22nd (Richard) and July 28th (Otto) Conference Call Information: 763.315.6900 (toll number) 866.448.6756 (toll-free number) Participant Code: 6828319 (followed by #) NOTE: if you are not on travel, please dial the toll number when accessing the conference call Matthew Todd Regulatory Analysis and Scientific Affairs American Petroleum Institute 1220 L Street NW Washington, DC 20005 p: (202)682-8319 f: (202)682-8031 www.api.org SH ELL-MCCLU RG-OS41 04